 AstraZeneca plc NASDAQ: AZN is rumored to be eyeing take over of Mereo BioPharma Group plc NASDAQ: MREO, according to a report in The Times. The Times report says that Mereo would accept 5, equating to 500 million including American depositary receipts or ADRs. 